Insomnia is a common problem for children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Research has shown that daytime drowsiness because of insufficient sleep can lead to learning and attention problems.
A new clinical trial, posted November 2005 on the www.clinicaltrials. gov Web site, is recruiting children and adolescents with ADHD-related insomnia. The purpose of the study is to examine the effects of a nonstimulating drug, atomoxetinewhich is indicated for the treatment of ADHDon ADHD-related insomnia. A majority of drugs indicated for the treatment of ADHD symptoms in children and adults are stimulating and can aggravate sleep problems. There is evidence that the trial's drug may improve sleep in children with ADHD.
Women with abnormal vaginal microbiota showed no difference in efficacy of daily oral PrEP compared to women with normal vaginal microbiota.
Clinical features with downloadable PDFs